Niedrig dosierte Radiotherapie bei primärem orbitalem Marginalzonenlymphom

• Literatur

• 1 Bairey O, Kremer I, Rakowsky E. et al. Orbital and adnexal involvement in systemic non-Hodgkinʼs lymphoma. Cancer 1994; 73: 2395-2399
• 2 Ishii Y, Tomita N, Takasaki H. et al. Clinical features of extanodal marginal zone lymphoma of mucosa-associated lymphoid tissue. Hematol Oncol 2012; 30: 186-189
• 3 Coupland SE, Hummel M, Stein H. et al. Ocular adnexal lymphomas: five case presentations and a review of the literature. Surv Ophthalmol 2002; 47: 470-490
• 4 Lee JL, Kim MK, Lee KH. et al. Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa. Ann Hematol 2005; 84: 13-18
• 5 Russell W, Herskovic A, Gessert D. et al. Ocular adnexal MALTomas: case series of patients treated with primary radiation. Clin Adv Hematol Oncol 2013; 11: 209-214
• 6 Sjö LD. Ophthalmic lymphoma: epidemiology and pathogenesis. Acta Ophthalmol 2009; 87: 1-20
• 7 Goda JS, Gospodarowicz M, Pintilie M. et al. Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy. Cancer 2010; 116: 3815-3824
• 8 Akhtari M, Reddy JP, Pinnix CC. et al. Primary cutaneous B-cell lymphoma (non leg-type) has excellent outcomes even after very low dose radiation as single-modality therapy. Leuk Lymphoma 2016; 57: 34-38
• 9 Hoskin PJ, Kirkwood AA, Popova B. et al. 4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial. Lancet Oncol 2014; 15: 457-463